Green genes from blue greens: challenges and solutions to unlocking the potential of cyanobacteria in drug discovery
Authors:
- Benjamin PhilmusBPBenjamin Philmus
- Nicole E. AvalonNANicole E. Avalon
- Yousong DingYDYousong Ding
- Drew T. DoeringDDDrew T. Doering
- Alessandra S. EustáquioAEAlessandra S. Eustáquio
- William H. GerwickWGWilliam H. Gerwick
- Hendrik LueschHLHendrik Luesch
- Jimmy OrjalaJOJimmy Orjala
- Shaz SutherlandSSShaz Sutherland
- Arnaud TatonATArnaud Taton
- Daniel UdwaryDUDaniel Udwary
Open Access
- 15 July 2025
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Natural Product Reports
- Vol. 43 (2) , 286-300
Abstract
Cyanobacteria are prolific producers of bioactive natural products. In this article, we outline some challenges faced in exploiting cyanobacteria for drug discovery, current solutions, and pathways forward to fully explore them for drug discovery.Keywords
Funding Information
- National Center for Complementary and Integrative Health (T32AT010131)
- Joint Genome Institute (DE-AC02-05CH11231)
- Division of Cancer Prevention, National Cancer Institute (P01 CA125066)
- National Institute of General Medical Sciences (5R01GM107550)
- National Institute of General Medical Sciences (R15GM117541)
- National Institute of General Medical Sciences (R35GM118290)
- National Institute of General Medical Sciences (R35GM128742)
- National Institute of General Medical Sciences (RM1GM145426)
This publication has 126 references indexed in Scilit:
- CRISPR-Cas mediated genome engineering of cyanobacteria2022
- Deciphering Chemical Mediators Regulating Specialized Metabolism in a Symbiotic CyanobacteriumAngewandte Chemie International Edition, 2022
- SMART‐Miner: A convolutional neural network‐based metabolite identification from 1 H‐ 13 C HSQC spectraMagnetic Resonance in Chemistry, 2021
- Crystalline Sponge Method: X‐ray Structure Analysis of Small Molecules by Post‐Orientation within Porous Crystals—Principle and Proof‐of‐Concept StudiesAngewandte Chemie International Edition, 2021
- Computer Assisted Structure Elucidation (CASE): Current and future perspectivesMagnetic Resonance in Chemistry, 2020
- Alcohol‐tolerant mutants of cyanobacterium Synechococcus elongatus PCC 7942 obtained by single‐cell mutant screening systemBiotechnology and Bioengineering, 2017
- The Carmaphycins: New Proteasome Inhibitors Exhibiting an α,β‐Epoxyketone Warhead from a Marine CyanobacteriumChemBioChem, 2012
- Inhibition of protein phosphatases by microcystis and nodularin associated with hepatotoxicityJournal of Cancer Research and Clinical Oncology, 1990
- Cyanobacterial microcystin‐LR is a potent and specific inhibitor of protein phosphatases 1 and 2A from both mammals and higher plantsFEBS Letters, 1990
- Identification of common molecular subsequencesJournal of Molecular Biology, 1981